Steven Cohen Axogen, Inc. Transaction History

Point72 Asset Management, L.P.

$36.6 Billion
Q3 2024

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Axogen, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 17,100 shares of AXGN stock, worth $280,440. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,100

Holding current value

$280,440

% of portfolio

0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$7.52 - $14.69 $128,591 - $251,199	17,100 New	17,100 $239,000
Q1 2023 May 15, 2023	SELL	$7.53 - $10.95 $6.7 Million - $9.74 Million	-889,400 Reduced 49.0%	925,600 $8.75 Million
Q4 2022 Feb 14, 2023	SELL	$9.44 - $13.09 $3.3 Million - $4.58 Million	-349,722 Reduced 16.16%	1,815,000 $18.1 Million
Q3 2022 Nov 14, 2022	BUY	$8.14 - $12.25 $641,765 - $965,802	78,841 Added 3.78%	2,164,722 $25.8 Million
Q2 2022 Aug 15, 2022	BUY	$6.99 - $10.0 $14.6 Million - $20.9 Million	2,085,881 New	2,085,881 $17.1 Million
Q4 2021 Feb 14, 2022	SELL	$8.8 - $16.0 $9.89 Million - $18 Million	-1,124,337 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$15.23 - $21.72 $1.92 Million - $2.74 Million	-126,021 Reduced 10.08%	1,124,337 $17.8 Million
Q2 2021 Aug 16, 2021	BUY	$17.8 - $23.5 $11.3 Million - $15 Million	636,625 Added 103.73%	1,250,358 $27 Million
Q1 2021 May 17, 2021	BUY	$17.18 - $22.6 $7.98 Million - $10.5 Million	464,556 Added 311.41%	613,733 $12.4 Million
Q4 2020 Feb 16, 2021	BUY	$11.5 - $17.96 $1.72 Million - $2.68 Million	149,177 New	149,177 $2.67 Million
Q1 2020 May 15, 2020	SELL	$8.38 - $17.34 $1.16 Million - $2.4 Million	-138,594 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$11.18 - $18.6 $1.55 Million - $2.58 Million	138,594 New	138,594 $2.48 Million
Q3 2019 Nov 15, 2019	SELL	$12.09 - $20.46 $7.19 Million - $12.2 Million	-595,084 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$18.5 - $25.47 $4.75 Million - $6.54 Million	256,697 Added 75.86%	595,084 $11.8 Million
Q1 2019 May 15, 2019	BUY	$14.62 - $22.13 $4.95 Million - $7.49 Million	338,387 New	338,387 $7.13 Million
Q1 2018 May 15, 2018	SELL	$24.4 - $40.25 $280,600 - $462,875	-11,500 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$18.5 - $28.6 $212,750 - $328,900	11,500	11,500 $325,000

Others Institutions Holding AXGN

# of Institutions

162

Shares Held

36.6M

Call Options Held

230K

Put Options Held

400

View Full List

About Axogen, Inc.

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $693M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

More about AXGN

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account